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Nitrendipine, a classical blocker of L-type Ca"' channels, is shown to be a potent inhibitor of the Ca:'-activated K* channel of human erythroc.vtes. 
In er:ithrocytes suspended in a solution with physiological Na ~ and K* concentrations and in which the channel was activated using the Ca-'" 
ionophore ionom~,cin, nitrendipene inhibited K*(~'Rb ") influx with an 1~0 of around 130 nM. Similar results were obtained for K*(mRb ") efflux, 
and for K+(K~Rb +) i,~flux into cells suspended ina high-K" medium. 
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1, INTRODUCTION 
Ca~"--activated K'- (K~'(Ca-~*)) channels were first 
identified in human erythrocytes [I] and are now known 
to be present in most cell types [2-4]. They show a wide 
range of  single-channel conductances and differ in their 
dependence on Ca '~* and voltage. The most potent and 
selective known inhibitors or these channels are inver- 
tebrate toxins. Apamin, from bee venom, blocks low 
conductance K+(Ca -~) channels at nanomolar con- 
centrations; it has no effect on high or intermediate 
conductance K'(Ca :~) channels, nor on other types of 
K + channels [4]. Charybdotoxin, from the scorpion 
Leiurus quinquestriatus i also highly potent but has a 
wider spectrum or action; it blocks high and inter- 
mediate conductance K+(Ca '-÷) channels (such as the 
'Gardos channel' or human erythrocytes) at nanomolar 
concentrations [5], but other types of' K + channels are 
also affected. These toxins serve as useful experimental 
tools but their use is restricted by their e:~pense and 
limited availability. Consequently, much of the work on 
K'(Ca -'') channels has involved the use or low-molecu- 
lar-weight organic inhibitors, such as quinine, quinidine 
[6] and tetra-alkylammonium derivatives [7]. These are 
generally inexpensive and are widely available; how- 
ever, when used at the relatively high concentrations 
that are necessary for full inhibition of K+(Ca '÷) 
channels (usually > 0.1 raM), such compounds are 
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notoriously non-specific and are known to influence a 
wide range of membrane processes. 
Nitrendipine is well established as a blocker of L-type 
Ca channels [8]. We report here that it inhibits the 
K~(Ca -~) channel of human erythroeytes at sub-micro- 
molar concentrations and is therefore the most potent 
low-molecular-weight inhibitor of this pathway re- 
ported to date. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
~6RbCI was front NEN (UK). Ouabain and nifedipine were from 
Siena Chemical Co. and bumetanide was a gilt from Leo Labo- 
ratories (Aylesbury, Bucks.). Nitrendipine was a gift from M.W. Wo. 
Iowyk. BAPTA-AM and ionomycin were from Caibiochem Corpora- 
tion (CA, USA). All buffer reagents were of analytical grade. 
2.2, Erythroo,tes 
Freshly drawn heparinirmd blood from three healthy donors was 
washed three times (by eentrifugation for 4 rain at 800 × g) in MOPS- 
buffered saline (134.4 mM NaCI, 5 mM KCI, 0.24 mM MgCI:, 15 mM 
MOPS, 10 mM glucose, pH 7.4) and the huffy coat was removed by 
aspiration. 
2,3. K" (~ Rb " ) flux measurements 
Aliquots of the washed erythrocyte suspension were dispensed into 
microcentrifuge tubes containing either the low-K" washing solution 
(as above) of a high-K* saline ( 140 mM KCI, 0.24 mM MgCl:, 15 mM 
MOPS, I0 mM glucose, pH 7.4) so as to give final extracellular K* 
con~ntrations of 5 or 80 raM. The final samples had a volume of 1.0 
ml and a haematocrit ofareund 3%. All samples contained ouabain 
(0.1 raM), bumetanide (0.1 raM) and CaCI2 (0.4 raM). The K'(Ca -~') 
channel was activated by the addition of the Ca ionophore ionomyein 
(1 mM in DMSO) to a final concentration f !/.tM. For ¢~lls in a 
low-K medium, activation ot' the channel with a Ca-" ionophore leads 
to an immediate membrane hyperpolarisation a d a subsequent ~11 
shrinkage and intracellular acidification [9]; in the experiments in
which c¢lh were suspended atan extraeellular K* concentration f 5 
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raM, nitrendipine was added (at the appropriate concentration), the 
samples were transferred to a 37°C water bath for 10 mix, then 
ionomycin was added immediately before commencing the flux, For 
cells suspended at an extraeeilular K + concentration of 80 mM the 
transmembrane K + distribution was close to electrochemical equilib- 
rium and the cells therefore remained in an approximately steady state 
on activation of the channel [9], In these experiments he ionophore 
was added, then the cells were incubated at 37°C for at least 10 mix 
before adding nitrendipine, then commencing the flux by the addition 
of ~Rb*, 
In preliminary experiments it was found that the influx of~'Rb ÷ into 
cells treated with ionomycin appeared approximately linear with tlme 
for up to < 4 mix (in both high-K and low-K media), Unidirectional 
K influx was therefore stimated from the ~6Rb" accumulated within 
a fixed l-mix incubation period, a~Rb" was added at the final activity 
of approximately 5 #Ci, ml 4. The flux was terminated by the addition 
of quinine (0,87 mM in ice.cold saline, 300 #1) to the flux suspension, 
then four (300 #l) aliquots of the suspension were transferred immedi- 
ately to microeentrifuge tube~ containing 800/~1 of ice-cold saline (with 
0,1 mM qulnlne) layered over 250 yl of dibutylphthalate, The tubes 
were centrifuged (10 000 x g, 15 s) to sediment the cells below the oil, 
then the supernatant solution was a~plrated, Each tube was rinsed 
three times with water, then the dibutylphthalate was aspirated, The 
cell pellet was lysed with 0,1% (v/v) Triton X-100 (0,5 ml), then de- 
proteinised by the addition of 5% (w/v) TCA (0,5 ml) followed by 
centrifugation (10 000 × g, 10 mix), The ~Rb + in the supernatant 
solutions was measured using Cerenkov counting,. The extracellular 
radioactivity trapped in the cell pellets was estimated from aliquots 
taken from an ice.cold sample to which the quinine "stopping solution' 
had been added prior to the ~Rb ÷, K(~Rb +) efflux measurements were 
carried out as has been described elsewhere [10], 
2.4. "~Ca it~u.~: Hlllecottrsv #lv~la'ltrel)lgllls 
Washed erythrocytes were restaspended to a haematocrit of 10% in 
a solution containing 145 mM NaCl. 5 mM KCI, l0 mM MOPS, 5 
mM glucose and 0,1 mM EGTA (pH 7.4), BAPTA-AM was added 
(final concentration 0,3 raM) and the cells incubated (37'C. 90 rain) 
to allow for the uptake and hydrolysis intraccllularly of the e~ter to 
the Ca:'.chelatin~ free acid (BAPTA; [11]). Following the incubation, 
the cells were washed twice in a solution containing 70 mM NaCI, 80 
mM KCI, 0,15 mM MeCh. and 10 mM HEPES (pH 7,4), then dis- 
pensed into a microcentrifuge tube. lonomycin was added to a final 
concentration of 1 MM. The final sample volume was 1,5 ml and the 
haematocrit was 5%, CaCI: (containing trace amounts of 4~Ca :+) was 
added to a concentration f0,4 mM (and a final activity of I/.tCi, ml-h), 
then the tube was p la id  at 37°C. lntracellular Ca 2. was chelated 
by BAPTA, preventing its extrusion by the Ca:* pump [11], At 20-30 
s time interva!i, aliquots (100 #1) of the sasl~nsion were taken from 
the flux tube and transferred to microeentrifu~e tubes containing 800 
#1 of ice-cold saline layered over 250/.tl ofdibutylphthalate. The tubes 
were centrifuged immediately (10 000 × g, 15 s) then proct.'ssed as 
described above for "~Rb* influx. The anaount of ~Ca;" in the TCA 
supernatant was measured by fl-scintillation spectroscopy, 
3. RESULTS AND DISCUSSION 
Fig. 1 presents inhibition data for nitrendipine at con- 
centrations from 10 -s to 10 -S M on a6Rb influx through 
the erythrocyte K*(Ca :÷) channel. Results are presented 
in both low.K (5 raM) and high-K (80 mM) media, and 
give similar inhibition, with an/so value of around 130 
nM. Confirmatory experiments measuring the Ca~'+-in - 
dueed a6Rb efflux from pro-loaded cells gave similar lso 
values of 100-130 nM for nitrendipine inhibition. In a 
necessary control experiment, ~Ca influx was measured 
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Fig. 1. The effect of nitrendipine (circles) and nifedipin¢ (triangles) on 
K*(~Rb ÷) influx via the K*(Ca 2.) channel of normal human ery- 
throcytes uspended in solutions containing 5mM (open symbols) or 
80 mM (closed symbols) K ÷, Influx rates are expressed as a percentage 
of those measured in the absence of inhibitor. The results are averaged 
from experiments on cells from at least three different donors. Error 
bars indicate _'!- SEM and, where not shown, fall within the symbols, 
in ionomycin-treated erythrocytes, to establish that ni- 
trendipine was not acting via an inhibition of iono- 
my¢in-mediated Ca entry. In experiments on cells from 
three different donors there was no inhibition of 4Sea 
entry in cells treated with 1/aM nitrendipine. 
Fig. 1 also shows data for the effect of nifedipine, 
another dihydropyridine, on ~6Rb + influx through the 
K+(Ca 2+) channel of erythrocytes suspended in a low- 
K + medium. The I~ was around 3/.tM, somewhat less 
than the value of 18.7/aM reported by Kaji [12] for the 
inhibition by nifedipine of K*(S6Rb +) efflux via the ery- 
throcyte K+(Ca :*) channel, but still more than 20-fold 
higher than that observed for nitrendipine in the present 
study. 
The present results identify nitrendipine as a con- 
venient high.affinity blocker for studying Ca2+-acti - 
rated K* channels. Additionally, K+(Ca 2+) channel 
blockade must be taken ipto account when considering 
the action of nitrendipine in other cell types. The I50 for 
the inhibition of the erythrocyte K*(Ca :*) channel is 
similar to the value of 154 nM determined for inhibiting 
L-type calcium channels in the heart [8], suggesting that 
nitrendipine may be as potent (or even more potent) an 
inhibitor of the K + channel as it is of Ca "~+ channels. 
Finally, nitrendipine may offer an effective therapy 
for maintaining sickle cells in their hydrated state. K + 
loss via the erythrocyte K+(Ca 2+) channel is a poten- 
tially important cause of red cell dehydration i sickle- 
cell disease [13], the consequential ncrease in concentra- 
tion of sickle heamoglobin causing an expotential in- 
crease in its rate of poiymerisation a d loss of col! defor- 
mability [14]. Charybdotoxin, a highly potent inhibitor 
of the erythrocyte K+(Ca :*) channel [5], is known to 
protect against dehydration of sickle cells [15], as does 
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nitrendipine [16]. No trials o f  clinical efficacy o f  nitren- 
dipine in sickle-cell disease have been reported,  al- 
though a pi lot study of  7 pat ients  showed no improve-  
ment in b lood parameters  [17], Ni fedipine,  in a study o f  
11 patients [18], improved retinal and conjunct ival  
perfusion. The present results indicate the need for more  
substant ive clinical evaluat ion o f  nitrendipine in sickle- 
cell disease. 
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